APA

Albers-Wolthers C. H. J., de Gier J., Walen M., van Kooten P. J. S., Lambalk C. B., Leegwater P. A. J., Roelen B. A. J., Schaefers-Okkens A. C., Rutten V. P. M. G., Millar R. P. M. & Kooistra H. S. (20170920). In vitro and in vivo effects of kisspeptin antagonists p234, p271, p354, and p356 on GPR54 activation. : PloS one.

Chicago

Albers-Wolthers C H J, de Gier J, Walen M, van Kooten P J S, Lambalk C B, Leegwater P A J, Roelen B A J, Schaefers-Okkens A C, Rutten V P M G, Millar R P M and Kooistra H S. 20170920. In vitro and in vivo effects of kisspeptin antagonists p234, p271, p354, and p356 on GPR54 activation. : PloS one.

Harvard

Albers-Wolthers C. H. J., de Gier J., Walen M., van Kooten P. J. S., Lambalk C. B., Leegwater P. A. J., Roelen B. A. J., Schaefers-Okkens A. C., Rutten V. P. M. G., Millar R. P. M. and Kooistra H. S. (20170920). In vitro and in vivo effects of kisspeptin antagonists p234, p271, p354, and p356 on GPR54 activation. : PloS one.

MLA

Albers-Wolthers C H J, de Gier J, Walen M, van Kooten P J S, Lambalk C B, Leegwater P A J, Roelen B A J, Schaefers-Okkens A C, Rutten V P M G, Millar R P M and Kooistra H S. In vitro and in vivo effects of kisspeptin antagonists p234, p271, p354, and p356 on GPR54 activation. : PloS one. 20170920.